期刊文献+

胰高糖素样肽1对大鼠胰岛功能影响的研究 被引量:1

Study on the effect of glucagon-like peptide 1 on the functions of rat pancreatic islets
下载PDF
导出
摘要 目的:研究胰高糖素样肽-1(GLP-1)对大鼠胰岛功能的影响,探讨GLP鄄1在糖尿病治疗中的作用。方法:①GLP鄄1(10nmol/L)与原代培养的大鼠胰岛共孵育1天、3天和5天后,分别行葡萄糖刺激下的胰岛素分泌试验(GSIS),在试验的0、10、20及60min依次收集细胞培养上清液,放免法检测胰岛素水平的变化。或与GLP鄄1共育1天、3天、5天后分别收集各组胰岛细胞,RT鄄PCR法检测各组胰岛素基因表达的变化。②分别予不同浓度的GLP鄄1(0、1、10、102和103nmol/L)与大鼠胰岛细胞瘤细胞RINm5f共育24h,及GLP鄄1(10nmol/L)与RINm5f共育24h、48h及72h,MTT法检测各组A值变化。结果:①与GLP鄄1共育后,大鼠胰岛基础胰岛素分泌量增加(P<0.05),GSIS试验中各时间点胰岛素分泌量均升高(P<0.05),胰岛素基因的表达量呈时间依赖性升高,即予GLP鄄1刺激5天后,胰岛素基因表达量最高;②与GLP鄄1共育后,随GLP鄄1浓度的增高及刺激时间的延长,RINm5f细胞MTT法中A值呈剂量及时间依赖性的增加。结论:GLP鄄1可促进大鼠胰岛细胞胰岛素基因的表达和蛋白的分泌,对大鼠胰岛细胞亦有明显的促增殖作用。 Objective: To investigate the effect of glucagon-like peptide 1 on the functions of rat pancreatic islets. Methods: ① Purified rat pancreatic islets were divided into three groups and cultured with or without GLP-1 for 1, 3, and 5 days. At the end of Day 1, 3, or 5, a glucose-induced insulin secretion test was performed, and the supernatants were collected to examine the insulin levels or the cellular pellets were collected to test the mRNA levels of insulin gene; ②Rat insulinoma cell line RINm5f was cultured with different concentrations of GLP-1 for various periods, and the OD values of each group were determined by MTT method. Results: ①After co-cultured with GLP-1, both the baseline and glucose-stimulated insulin production were increased compared to the control groups, and the expression of insulin gene level was also enhanced in GLP-1 groups; ② After co-cultured with GLP-1,the OD values were elevated in a dose and time-dependent manner. Conclusion: GLP-1 can not only increase the insulin gene expression and insulin secretion, but also stimulate the proliferation of islet cells.
出处 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2005年第7期464-467,共4页 Journal of Nanjing Medical University(Natural Sciences)
基金 江苏省政府医学重点学科项目基金[苏卫科教(2001)34]
关键词 胰高糖素样肽-1 胰岛 胰岛素 糖尿病 glucagons-like peptide 1 islet insulin diabetes mellitus
  • 相关文献

参考文献13

  • 1Flint A,Raben A,Astrup A,et al.Glueagan—like peptide 1 promote satiety and suppresses energy in take in humans[J].J Clin Invest,1998,101:515-520.
  • 2Schirra J,Katschinski M,Weidmann C,et al.Gastric emptying and release of incretin hormones after glucose ingestion in humans[J].J Clin Invest,1996,97:92—103.
  • 3Holz GG,Leech CA,Heller RS,et al.camp—dependent mobilization of intracellular Ca^2+ stores by activation of ryanodine receptors in pancreatic beta—cells.A Ca^2+ signaling system stimulated by the insulinotropic hormone glucagons—like peptide-1(7-36)[J].J Biol Chem,1999,274:14147—14156.
  • 4Gunnar S,Mehboob AH,George GH.Glucagons—like peptide-1 stimulates insulin gene promoter activity by protein kinase A independence activation of the rat insulin gene camp response element[J].Diabetes,2000,49:1156-1164.
  • 5Joel FH.Glucagons—like peptide-1 agonist stimulation of β-cell growth and differentiation[J].Cur Opinion in Endocrinol and Diabetes,2001,8:74-81.
  • 6Hongxiang Hui,Chris Wright,Richardo Perfetti.Glucagons-like peptide-1 induces differentiation of islet duodenal homeobox-1-positive pancreatic ductM cells into insulin—secreting cells[J].Diabetes,2001,50:785—796.
  • 7Nie Y, Nakashima M, Brubaker P L, et al. Regulation of pancreatic PC1 and PC2 associated with increased glucagon and GLP-1 immunoreactivity in diabetic rats[J]. J Clin Invest,2000,105: 955-965.
  • 8Xu G,Stoffers DA,Habener JF,et al.Exendin-4 stimulates both beta-cell replication and neogenesis,resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats [J]. Diabetes,1999,48:2270-2276.
  • 9Celile T,Danielle B,Marie JM,et al.Persistent improvement of type 2 diabetes in the Goto-Kakizaki rat model by expansion of the β-cell mass during the prediabetic period with glucagons-like peptide-1 or exendin-4 [J]. Diabetes,2001,50: 1562-1570.
  • 10Buteau J, Assaad EI, Rhodes C J, et al. Glucagons-like peptide-1 prevents beta cell glucolipotoxicity [J].Diabetologia,2004,47: 806-815.

同被引文献6

  • 1饶高峰,陈恩福,马永松,林海洋,周仁芳.二甲双胍对2型糖尿病患者高脂血症疗效观察[J].辽宁实用糖尿病杂志,2004,12(3):15-16. 被引量:1
  • 2陈树,张学军,张敏,王丹,李凤琼,程华英,饶绍琴,吴桐,邓尚平,岳欣.胰岛素或磺脲类药物联合二甲双胍治疗对2型糖尿病患者胰岛β细胞功能的影响[J].中华糖尿病杂志(1006-6187),2004,12(4):265-267. 被引量:4
  • 3Opara EC,Garfinkel M, Hubbard VS, et al. Effects of fatty acid on insulin release: Role of chain length and degree of unsaturation. Am J Physiol, 1994,266 :635 - 639.
  • 4Turner RC,Cull CA, Frighi V, et al. Glycemic control with diet,sulfonylurea,metformin,or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies(UK-PDS 49). JAMA, 1999,281(21) : 2005-2012.
  • 5Boonner-Weir S. Life and Death of the Pancreatic Cells. Trend Endoerinol Metab, 2000,11 : 375 - 378.
  • 6Rhodes CJ. Type 2 dibetes- a matter of- cell life and death. Science, 2005,307 : 380- 384.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部